Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer.
about
QSOX1 inhibits autophagic flux in breast cancer cellsMass spectrometry-based secretome analysis of non-small cell lung cancer cell lines.Candidate chromosome 1 disease susceptibility genes for Sjogren's syndrome xerostomia are narrowed by novel NOD.B10 congenic mice.The emerging role of QSOX1 in cancerEbselen inhibits QSOX1 enzymatic activity and suppresses invasion of pancreatic and renal cancer cell linesIlluminating luminal B: QSOX1 as a subtype-specific biomarkerGoing through the barrier: coupled disulfide exchange reactions promote efficient catalysis in quiescin sulfhydryl oxidaseExpression level of quiescin sulfhydryl oxidase 1 (QSOX1) in neuroblastomas.Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism.Disulfide bond generation in mammalian blood serum: detection and purification of quiescin-sulfhydryl oxidase.Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping.Reduced QSOX1 enhances radioresistance in nasopharyngeal carcinoma.QSOX1 expression is associated with aggressive tumor features and reduced survival in breast carcinomas.DNA-mediated dimerization on a compact sequence signature controls enhancer engagement and regulation by FOXA1.Correction to: Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in luminal B breast cancer
P2860
Q24324407-D3CE089E-1F53-416A-9968-97B1B02821CCQ30313775-8B8D186D-41FC-49C9-9884-144DFB6288C7Q33758184-9DDCB41C-F800-4AAD-BEA2-EC148D41AA33Q33828308-BE21D951-6EC8-40A8-9AE3-3786D3EBE95BQ35687202-93D4A96C-0D41-418B-ABB7-2B0C7EF9188BQ36998375-4D08E19F-172F-488B-B052-E0EA1B934AE3Q37596401-911B95CA-8195-4D1A-A93B-C586F46BD2C6Q37693075-3241F639-3EF1-4224-9C7F-D1DEE39CAECBQ37701609-EF98D0B3-18A2-4DD7-9456-579CFE7EC43AQ38368689-04D846CA-B42D-48D8-98B5-5AC1C7BC5294Q47100468-C7ACB1A5-5313-4C68-A518-44F5721A0B51Q50105730-28BE1923-CB1C-447A-8B15-D346571B1208Q51549817-082C7811-7978-4972-A032-B00F2690423AQ52691439-23EB8027-BCD4-4653-A95B-A4CD850A559DQ58796324-88F3A2BA-58DC-41F4-B043-34FF4BE5E341
P2860
Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expression of quiescin sulfhyd ...... is in Luminal B breast cancer.
@en
Expression of quiescin sulfhyd ...... is in Luminal B breast cancer.
@nl
type
label
Expression of quiescin sulfhyd ...... is in Luminal B breast cancer.
@en
Expression of quiescin sulfhyd ...... is in Luminal B breast cancer.
@nl
prefLabel
Expression of quiescin sulfhyd ...... is in Luminal B breast cancer.
@en
Expression of quiescin sulfhyd ...... is in Luminal B breast cancer.
@nl
P2093
P2860
P356
P1476
Expression of quiescin sulfhyd ...... is in Luminal B breast cancer.
@en
P2093
Aprill Watanabe
Benjamin A Katchman
Douglas F Lake
Galen Hostetter
Heather E Cunliffe
I Tolgay Ocal
Janine LoBello
Yu-Hui Chang
P2860
P2888
P356
10.1186/BCR3407
P577
2013-03-28T00:00:00Z
P5875
P6179
1036699852